Vanguard Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32M Sell
1,239,347
-242,605
-16% -$5.24M ﹤0.01% 2141
2026
Q2
$29.9M Sell
1,481,952
-61,703
-4% -$1.24M ﹤0.01% 2222
2026
Q1
$30.2M Buy
+1,543,655
New +$37.8M ﹤0.01% 2115

Other funds holding AMPH

Vanguard Capital Management's AMPH Position: Q3 2026 in Review

Vanguard Capital Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 16% in Q3 2026, selling an estimated $5.24M and leaving 1,239,347 shares worth $32M. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Vanguard Capital Management first reported a position in AMPH in Q1 2026 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Vanguard Capital Management held 1,239,347 shares of Amphastar Pharmaceuticals worth $32M as of Q3 2026.
  • Vanguard Capital Management sold 242,605 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $5.24M.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2141 holding.
  • Vanguard Capital Management first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.